OGT GeneSpect Somatic Reporter

OGT, a Sysmex Group company, has announced the release of GeneSpect Somatic Reporter for use with OGT’s SureSeq portfolio of next-generation sequencing (NGS) panels. This analytical reporting solution pairs state-of-the-art variant interpretation and reporting with OGT’s NGS panels and bioinformatics solutions. Users of SureSeq myeloid panels can now benefit from insightful tertiary reporting for all myeloid malignancy content and variants.

NGS has the potential to provide significant insight into cancer research, and clinicians need help deciphering this data. The SureSeq platform partnered with the somatic reporter helps to simplify this critical step, enabling users to maximise the benefits of their NGS data to progress our understanding of cancer.

Powered by Intelliseq’s iFlow engine, GeneSpect Somatic Reporter presents genomic data and relevant clinical associations in an expert-informed format optimised for the needs of NGS reporting for haematological cancers. iFlow engine integrates with OGT’s bioinformatics pipeline to generate clinically relevant variant interpretations, drug and therapy associations, clinical guidelines criteria and clinical trials associations for OGT customers.